Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 USD | +0.24% | 0.00% | -40.36% |
May. 06 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
Apr. 16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.36% | 37.82M | |
+2.80% | 108B | |
+10.24% | 105B | |
+1.57% | 23.46B | |
-12.30% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.69% | 17.19B | |
+6.25% | 13.99B | |
+36.32% | 12.53B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- HC Wainwright Adjusts SAB Biotherapeutics' Price Target to $2 From $4, Keeps Buy Rating